MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/sj.emboj.7601349

Медицинская библиотека · The EMBO journal · 2006

SPIN90/WISH interacts with PSD-95 and regulates dendritic spinogenesis via an N-WASP-independent mechanism.

Jinno Sadao, Onishi Akira, Hattori Shuhei, Dubreuil Maureen, Ueda Yo, Nishimura Keisuke, Okano Takaichi, Yamada Hirotaka, Yamamoto Wataru, Murata Koichi, Onizawa Hideo, Ebina Kosuke, Maeda Yuichi, Son Yonsu, Amuro Hideki, Hara Ryota, Hata Kenichiro, Shiba Hideyuki, Katayama Masaki, Watanabe Ryu, Hashimoto Motomu, Saegusa Jun

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

This multicentre, retrospective study aimed to compare retention and reasons for discontinuation between Janus kinase inhibitors (JAKi) and biologic DMARDs in patients with elderly-onset rheumatoid arthritis (EORA).

METHODS

Patients with RA enrolled in a Japanese multicentre observational registry between 2015 and 2022 were included. EORA was defined as RA with onset at age 60 or over. To adjust confounding factors by indication for initiation of TNF inhibitors (TNFi), IL-6 inhibitors (IL-6i), cytotoxic T-lymphocyte associated antigen 4 immunoglobulin (CTLA4-Ig) blockers, or JAKi, a propensity score based on baseline characteristics was used to compare drug retention. To assess the reasons for discontinuation, retention rates for ineffectiveness, adverse events and remission were analysed as secondary outcomes.

RESULTS

A total of 572 patients with 835 treatment courses were identified (314 TNFi, 175 IL-6i, 228 CTLA4-Ig and 118 JAKi). After adjusting for differences in baseline characteristics, drug retention was significantly higher for IL-6i (hazard ratio [HR] = 0.38; 95% CI: 0.27, 0.55; P < 0.01) as compared with TNFi. Discontinuation due to lack of effectiveness was lower with JAKi (HR = 0.38; 95% CI: 0.22, 0.66; P < 0.01) and IL-6i (HR = 0.29; 95% CI: 0.19, 0.46; P < 0.01) as compared with TNFi although CTLA4-Ig had a similar HR to TNFi. The adjusted incidence of discontinuation due to adverse events was higher for JAKi (HR = 2.86; 95% CI: 1.46, 5.59; P < 0.01) than for TNFi.

CONCLUSION

In EORA patients, IL-6i and JAKi had longer retention and less discontinuation due to ineffectiveness than TNFi. The potential risks of JAKi should be approached with an individualized perspective.

Для цитирования: Jinno Sadao, Onishi Akira, Hattori Shuhei, Dubreuil Maureen, Ueda Yo, Nishimura Keisuke, Okano Takaichi, Yamada Hirotaka, Yamamoto Wataru, Murata Koichi, Onizawa Hideo, Ebina Kosuke, Maeda Yuichi, Son Yonsu, Amuro Hideki, Hara Ryota, Hata Kenichiro, Shiba Hideyuki, Katayama Masaki, Watanabe Ryu, Hashimoto Motomu, Saegusa Jun. SPIN90/WISH interacts with PSD-95 and regulates dendritic spinogenesis via an N-WASP-independent mechanism.. The EMBO journal. 2006. DOI: 10.1038/sj.emboj.7601349.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.